GB9515754D0 - Compositions and methods for the prevention of symptoms of viral disease - Google Patents

Compositions and methods for the prevention of symptoms of viral disease

Info

Publication number
GB9515754D0
GB9515754D0 GB9515754A GB9515754A GB9515754D0 GB 9515754 D0 GB9515754 D0 GB 9515754D0 GB 9515754 A GB9515754 A GB 9515754A GB 9515754 A GB9515754 A GB 9515754A GB 9515754 D0 GB9515754 D0 GB 9515754D0
Authority
GB
United Kingdom
Prior art keywords
symptoms
prevention
compositions
methods
viral disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB9515754A
Other versions
GB2292081A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of GB9515754D0 publication Critical patent/GB9515754D0/en
Publication of GB2292081A publication Critical patent/GB2292081A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GB9515754A 1994-08-12 1995-08-01 The use of a Neuraminidase Inhibitor in combination with an Influenza Vaccine Withdrawn GB2292081A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9416365A GB9416365D0 (en) 1994-08-12 1994-08-12 Medicaments

Publications (2)

Publication Number Publication Date
GB9515754D0 true GB9515754D0 (en) 1995-10-04
GB2292081A GB2292081A (en) 1996-02-14

Family

ID=10759813

Family Applications (2)

Application Number Title Priority Date Filing Date
GB9416365A Pending GB9416365D0 (en) 1994-08-12 1994-08-12 Medicaments
GB9515754A Withdrawn GB2292081A (en) 1994-08-12 1995-08-01 The use of a Neuraminidase Inhibitor in combination with an Influenza Vaccine

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB9416365A Pending GB9416365D0 (en) 1994-08-12 1994-08-12 Medicaments

Country Status (1)

Country Link
GB (2) GB9416365D0 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455571B1 (en) 1998-04-23 2002-09-24 Abbott Laboratories Inhibitors of neuraminidases
US6593314B1 (en) 1999-10-19 2003-07-15 Abbott Laboratories Neuraminidase inhibitors
GB0106031D0 (en) * 2001-03-12 2001-05-02 Glaxo Group Ltd Use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP249A (en) * 1990-04-24 1993-03-17 Biota Scient Management Pty Ltd Anti-viral compounds.

Also Published As

Publication number Publication date
GB2292081A (en) 1996-02-14
GB9416365D0 (en) 1994-10-05

Similar Documents

Publication Publication Date Title
IL125735A0 (en) Pharmaceutical compositions for the treatment of glaucoma
ZA957247B (en) Pharmaceutical compositions
IL113329A0 (en) Benzamide-containing pharmaceutical compositions
GB9418609D0 (en) Pharmaceutical compositions
IL121730A0 (en) Process for the preparation of 2'-fluoro-5-methyl-beta-L-arabino-furanosyluridine
GB9503893D0 (en) Process for the preparation and purification of iodinated agents
GB9405229D0 (en) Compositions of matter
IL119225A (en) Pharmaceutical compositions for the treatment of asthma in mammals
ZA954469B (en) Pharmaceutical compositions
IL121096A0 (en) Pharmaceutical compositions for the treatment of liver disease
ZA977874B (en) Pharmaceutical compositions for treating viral diseases
EP0981357A4 (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
GB9515754D0 (en) Compositions and methods for the prevention of symptoms of viral disease
IL141551A0 (en) Compositions and methods for the treatment of immune related diseases
ZA959081B (en) Pharmaceutical compositions
EP0755262A4 (en) Composition for the treatment of lung disease
GB2295825B (en) Pharmaceutical compositions
EP0979234A4 (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
HUP0000569A3 (en) Use of equilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
HU9400096D0 (en) Pharmaceutical compositions
HU9601821D0 (en) Pharmaceutical compositions
HUP0000570A3 (en) Use of 17 alpha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
ZA986324B (en) Composition for the treatment of immunodeficiency disease
GB9707483D0 (en) Pharmaceutical compositions
ZA953839B (en) The administration of magnesium

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)